Sign In
Buy STE
$228.40
-2.81 (-1.22%)
At Close: Jul 31, 2026
Comparing STERIS (NYSE:STE) & Ortho Regenerative Technologies (OTCMKTS:ORTIF)
04:12am, Sunday, 14'th Nov 2021 Transcript Daily
STERIS (NYSE:STE) and Ortho Regenerative Technologies (OTCMKTS:ORTIF) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, analyst recommendations, earnings, institutional ownership and profitability. Insider and Institutional Ownership 90.0% of STERIS shares are held by institutional investors. 1.1% of STERIS []
STERIS (STE) Q2 Earnings Surpass Estimates, Margins Down
10:42am, Thursday, 04'th Nov 2021
Solid growth across all three reporting segments drove STERIS' (STE) second-quarter fiscal 2022 revenues.
STERIS plc (STE) CEO Dan Carestio on Q2 2022 results - Earnings Call Transcript
12:50pm, Wednesday, 03'rd Nov 2021
STERIS plc (STE) CEO Dan Carestio on Q2 2022 results - Earnings Call Transcript
Medical Products Stock Earnings on Nov 2: IDXX, STE & More
12:15pm, Monday, 01'st Nov 2021
With the pandemic raging on, testing, vaccine and therapeutic makers are witnessing huge market adoption of their COVID-related support products in Q3.
STERIS (STE) to Report Q2 Earnings: What's in the Cards?
12:13pm, Thursday, 28'th Oct 2021
Strong gains from the recent Cantel Medical buyout as well as the addition of a new Dental arm are expected to have contributed STERIS' (STE) Q2 performance.
STERIS to Host a Conference Call for Fiscal 2022 Second Quarter Financial Results on November 3, 2021
04:30pm, Wednesday, 20'th Oct 2021
Dublin, Ireland, Oct. 20, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 second quar
Here's Why You Should Add STERIS (STE) to Your Portfolio
11:06am, Friday, 08'th Oct 2021
Investors are optimistic about STERIS (STE) owing to elevated consumer demand and rebound in procedure volumes and raised 2022 outlook.
Steris (STE) Upgraded to Buy: What Does It Mean for the Stock?
02:02pm, Friday, 01'st Oct 2021
Steris (STE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Steris (STE) Down 1.5% Since Last Earnings Report: Can It Rebound?
01:16pm, Wednesday, 08'th Sep 2021
Steris (STE) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Add STERIS (STE) to Your Portfolio Now
10:01am, Monday, 06'th Sep 2021
STERIS (STE) ended first-quarter fiscal 2022 with better-than-expected results and strong segmental performance, driving the top line.
21 Upcoming Dividend Increases Including 1 Dividend King
11:00am, Thursday, 26'th Aug 2021
All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 10.3% and a median increase of 6.7%.
STERIS (STE) Q1 Earnings Beat Estimates, 2022 Guidance Up
09:26am, Wednesday, 11'th Aug 2021
STERIS (STE) reported better-than-expected revenues for first-quarter fiscal 2022 on strong segmental performance driving the top line.
STERIS plc (STE) CEO Dan Carestio on Q1 2022 Results - Earnings Call Transcript
01:28pm, Tuesday, 10'th Aug 2021
STERIS plc (STE) CEO Dan Carestio on Q1 2022 Results - Earnings Call Transcript
STERIS Announces Financial Results for Fiscal 2022 First Quarter
04:30pm, Monday, 09'th Aug 2021
DUBLIN, IRELAND, Aug. 09, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2022 first quarter ended June 30, 2021. R
5 Top Buy-Rated Stocks With Dividend Hikes Expected This Week
11:08am, Monday, 09'th Aug 2021
After years of a low interest rate environment, many investors have turned to equities not only for the growth potential but also for solid and dependable dividends that help to provide an income stre
